Drug intelligence / Profile preview

lidocaine + hydromorphone

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Intravenous, Epidural, Intrathecal, Subcutaneous, Intramuscular, Local Infiltration
01

Overview

Lidocaine + hydromorphone is a combination of two pharmaceutical agents used primarily for pain management, particularly in settings where both local anesthesia and systemic opioid analgesia are desired. Lidocaine is an amide-type local anesthetic that works by blocking sodium channels on neuronal cell membranes, thereby inhibiting nerve impulse conduction and producing localized numbness or loss of sensation[2][9]. Hydromorphone is a potent opioid analgesic that acts as an agonist at the mu-opioid receptor in the central nervous system, altering the perception and response to pain[1][7][10]. This combination may be used in clinical scenarios such as perioperative pain control or severe acute pain when both rapid-onset local anesthesia and strong systemic analgesia are required. The use of this combination requires careful monitoring due to additive risks of central nervous system depression, respiratory depression, sedation, hypotension, and other adverse effects[5].

02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on lidocaine + hydromorphone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + hydromorphone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call